MedPath

citrulline supplementation to reduce adverse pregnancy outcomes

Phase 3
Not yet recruiting
Conditions
Pregnancy and Childbirth
Registration Number
PACTR202303697293140
Lead Sponsor
The Liverpool School of Tropical Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
2960
Inclusion Criteria

Pregnant women aged 16 to 40 years,
Gestation should be less than 24 weeks cornfirmed by ultrasound
The pregnancy should be viable singleton pregnancy
The woman should be a residents of the study area, willing to adhere to scheduled and unscheduledstudy visit procedures, and willing to deliver in a study clinic or hospital.

Exclusion Criteria

Multiple pregnancies
Pre-existing hypertension,
women with renal disease and/or diabetes, or severe anaemia (Hb < 5 g/dL)
HIV-positive women
Malformations or nonviable pregnancy observed on enrolment ultrasound
known allergy or contraindication to any of the study supplements
unable to give consent
Concurrent participation in any other clinical trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.